Health care financing policy for hospitalized rheumatology patients

E. Munoz, J. Goldstein, Teresa Benacquista, K. Mulloy, L. Wise

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The federal Medicare Diagnostic Related Group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective 'All Payor Systems' for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross and other commercial insurers, pay by the DRG mode; New York State has been All Payor since January 1, 1988. This study stimulated DRG All Payor methods on a sample (N = 298) of rheumatology patients for a 3-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital length of stay and total hospital cost compared to patients from Blue Cross and other commercial payors. All payors (i.e., Medicaid, Blue Cross, Medicare and commercial insurors) generated significant financial risk under the DRG All Payor scheme. If these findings are replicated at other hospitals, rheumatology patients could suffer a decline in both access and quality of care.

Original languageEnglish (US)
Pages (from-to)885-889
Number of pages5
JournalJournal of Rheumatology
Volume16
Issue number7
StatePublished - 1989

Fingerprint

Healthcare Financing
Diagnosis-Related Groups
Rheumatology
Blue Cross Blue Shield Insurance Plans
Medicare
Delivery of Health Care
Medicaid
Length of Stay
Insurance Carriers
Hospital Costs
Quality of Health Care

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Munoz, E., Goldstein, J., Benacquista, T., Mulloy, K., & Wise, L. (1989). Health care financing policy for hospitalized rheumatology patients. Journal of Rheumatology, 16(7), 885-889.

Health care financing policy for hospitalized rheumatology patients. / Munoz, E.; Goldstein, J.; Benacquista, Teresa; Mulloy, K.; Wise, L.

In: Journal of Rheumatology, Vol. 16, No. 7, 1989, p. 885-889.

Research output: Contribution to journalArticle

Munoz, E, Goldstein, J, Benacquista, T, Mulloy, K & Wise, L 1989, 'Health care financing policy for hospitalized rheumatology patients', Journal of Rheumatology, vol. 16, no. 7, pp. 885-889.
Munoz, E. ; Goldstein, J. ; Benacquista, Teresa ; Mulloy, K. ; Wise, L. / Health care financing policy for hospitalized rheumatology patients. In: Journal of Rheumatology. 1989 ; Vol. 16, No. 7. pp. 885-889.
@article{053a428d57db417f92f5056877195064,
title = "Health care financing policy for hospitalized rheumatology patients",
abstract = "The federal Medicare Diagnostic Related Group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective 'All Payor Systems' for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross and other commercial insurers, pay by the DRG mode; New York State has been All Payor since January 1, 1988. This study stimulated DRG All Payor methods on a sample (N = 298) of rheumatology patients for a 3-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital length of stay and total hospital cost compared to patients from Blue Cross and other commercial payors. All payors (i.e., Medicaid, Blue Cross, Medicare and commercial insurors) generated significant financial risk under the DRG All Payor scheme. If these findings are replicated at other hospitals, rheumatology patients could suffer a decline in both access and quality of care.",
author = "E. Munoz and J. Goldstein and Teresa Benacquista and K. Mulloy and L. Wise",
year = "1989",
language = "English (US)",
volume = "16",
pages = "885--889",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "7",

}

TY - JOUR

T1 - Health care financing policy for hospitalized rheumatology patients

AU - Munoz, E.

AU - Goldstein, J.

AU - Benacquista, Teresa

AU - Mulloy, K.

AU - Wise, L.

PY - 1989

Y1 - 1989

N2 - The federal Medicare Diagnostic Related Group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective 'All Payor Systems' for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross and other commercial insurers, pay by the DRG mode; New York State has been All Payor since January 1, 1988. This study stimulated DRG All Payor methods on a sample (N = 298) of rheumatology patients for a 3-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital length of stay and total hospital cost compared to patients from Blue Cross and other commercial payors. All payors (i.e., Medicaid, Blue Cross, Medicare and commercial insurors) generated significant financial risk under the DRG All Payor scheme. If these findings are replicated at other hospitals, rheumatology patients could suffer a decline in both access and quality of care.

AB - The federal Medicare Diagnostic Related Group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective 'All Payor Systems' for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross and other commercial insurers, pay by the DRG mode; New York State has been All Payor since January 1, 1988. This study stimulated DRG All Payor methods on a sample (N = 298) of rheumatology patients for a 3-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital length of stay and total hospital cost compared to patients from Blue Cross and other commercial payors. All payors (i.e., Medicaid, Blue Cross, Medicare and commercial insurors) generated significant financial risk under the DRG All Payor scheme. If these findings are replicated at other hospitals, rheumatology patients could suffer a decline in both access and quality of care.

UR - http://www.scopus.com/inward/record.url?scp=0024439998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024439998&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 885

EP - 889

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 7

ER -